About Us | Contact

Ravikumar K Patel Investigator

Newberry County Memorial Hospital NPI1629285150
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$33,911.69
from 13 payments in the last 6 years

Total Cash or Cash Equivalent

$33,372.79
from 6 payments in the last 6 years

Total In-kind Items & Services

$538.90
from 7 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
12/09/2021 Research Cash or cash equivalent $38.00 Details
Payment from Orexo US, Inc.
Paymment Research Study OXD01-001
Payment Record ID 851874809
11/18/2021 Research Cash or cash equivalent $6285.32 Details
Payment from Orexo US, Inc.
Paymment Research Study OXD01-001
Payment Record ID 851874535
12/09/2021 Research Cash or cash equivalent $38.00 Details
Payment from Orexo US, Inc.
Paymment Research Study OXD01-001
Payment Record ID 851874503
04/16/2021 Research In-kind items and services $39.59 Details
Payment from Eli Lilly and Company
Paymment Research Study A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3819253 AND LY3832479 IN PARTICIPANTS WITH MILD TO MODERATE COVID-19 ILLNESS
Clinical Trials Gov ID NCT04427501
Payment Record ID 819446283
07/12/2021 Research Cash or cash equivalent $13500.00 Details
Payment from Eli Lilly and Company
Paymment Research Study A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MONO AND COMBINATION THERAPY WITH MONOCLONAL ANTIBODIES IN PARTICIPANTS WITH MILD TO MODERATE COVID-19 ILLNESS (BLAZE-4)
Clinical Trials Gov ID NCT04634409
Payment Record ID 819446207
07/12/2021 Research Cash or cash equivalent $13500.00 Details
Payment from Eli Lilly and Company
Paymment Research Study A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3819253 AND LY3832479 IN PARTICIPANTS WITH MILD TO MODERATE COVID-19 ILLNESS
Clinical Trials Gov ID NCT04427501
Payment Record ID 819446155
05/18/2021 Research In-kind items and services $297.50 Details
Payment from Eli Lilly and Company
Paymment Research Study A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MONO AND COMBINATION THERAPY WITH MONOCLONAL ANTIBODIES IN PARTICIPANTS WITH MILD TO MODERATE COVID-19 ILLNESS (BLAZE-4)
Clinical Trials Gov ID NCT04634409
Payment Record ID 819445045
01/10/2019 General (Non-Research) In-kind items and services Food and Beverage $12.29 Details
Payment from Mallinckrodt Enterprises LLC
Payment Record ID 704794231
09/27/2019 General (Non-Research) In-kind items and services Food and Beverage $13.90 Details
Payment from TETRAPHASE PHARMACEUTICALS, INC.
Payment Record ID 693348727
11/14/2019 General (Non-Research) In-kind items and services Food and Beverage $56.62 Details
Payment from Allergan Inc.
Payment Record ID 670930161
03/15/2018 General (Non-Research) In-kind items and services Food and Beverage $11.40 Details
Payment from PFIZER INC.
Payment Record ID 610066961
10/25/2018 General (Non-Research) In-kind items and services Food and Beverage $107.60 Details
Payment from Boehringer Ingelheim Pharmaceuticals, Inc.
Payment Record ID 578447045
12/02/2016 General (Non-Research) Cash or cash equivalent Food and Beverage $11.47 Details
Payment from Indivior Inc.
Payment Record ID 411849380
;